Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-01-04 @ 12:01 AM
Study NCT ID:
NCT00545766
Status:
COMPLETED
Last Update Posted:
2021-12-16
First Post:
2007-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-15
First Submit QC Date:
None
Study First Post Date:
2007-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-02-25
Results First Submit QC Date:
None
Results First Post Date:
2013-04-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-14
Last Update Post Date:
2021-12-16
Last Update Post Date Type:
ACTUAL